Biotech Sector Moves Up In Tiny Steps
Risk Remains On
AACR Next Week Will Move Cancer Stocks
Biotech indices and ETFs are trying to hit new highs but momentum is easing and trading is choppy. Nonetheless we are moving up from the brief correction near channel lows at the end of Q1. Sentiment remains strong.
Here is a review of the Five Trends we […]
In the ongoing bad-news-is-good-news saga, last week’s surprisingly weak jobs report led to speculation that the Fed would delay hiking interest rates, which is perceived as a positive for equity investors. So, bulls are getting a boost for the moment, although those previously hard-won round-number price levels for the major indexes are now serving as ominous overhead resistance that will […]
The “Good Friday” Jobs Report may be one of the most anticlimactic in memory as the sharp slowdown in the jobs growth rate ran smack into a market closed for the holiday weekend and while it truly was a good Friday for anyone still long the PowerShares DB US Dollar Index Bullish Fund (UUP), what sort of situation will investors […]
This Weekend my eyes and thoughts curved around the Healthcare sector. I read several interesting articles from the sector, mostly about the biotech’s and new Hepatitis C drugs from Gilead, Sovaldi and Harvoni.Those are very expensive drugs with potential to kill the current medical systems but they also generate tons of cash for their corporate.I also noticed that the Healthcare […]
Three months into the new year and the broad U.S. equity indices have made limited progress to the upside. The Nasdaq composite lead by the healthcare/biotech and select semiconductor sectors has risen 3.28%, while the S&P 500 is essentially flat and the DJIA has actually declined six tenths of 1 percent.If you’ve been nimble and picked the right stocks in […]
GILD Stock Continues Recovery From Monday’s FallGilead Sciences, Inc. (NASDAQ: GILD)GILD stocks fell hard Monday; losing more than two percent as the company issued a warning to doctors treating their patients with Sovaldi in combination with antiarrhythmics. However, the slide stopped and the stock started to move in the positive direction. Today, it seems as though the stock is staying […]
View gallery.Biotech stocks have been breaking to new highs all over the market. Here are just a few:Esperion Therapeutics broke to a new high last week and skyrocketed Tuesday.
Ampio Pharmaceuticals bolted higher last week and touched a new high Wednesday.
Jazz Pharmaceuticals just hit a new high Wednesday as well.
The list goes on and on. Whether it is Receptos, NewLink Genetics, Biogen […]
Biotech and Healthcare Stocks Hit New Highs
The market roared back today with healthcare and biotech the strongest sectors.The Healthcare Select SPDR ETF (XLV) was up 2.21% to $73.40. This is a 52 week high. The Euro rallied 1% to 1.057 and that helped large cap companies with revenues outside the US. The XBI SPDR Biotech ETF (XBI) also hit a […]
View photo.Biotech stocks have performed well in the recent bull market.Since January 1, 2008, the SPDR S&P Biotech ETF (NYSE: XBI) has outperformed the SPDR S&P 500 ETF Trust (NYSE: SPY), gaining 233 percent compared with just 41.3 percent gains in SPY.Analysts at Sterne Agee took a closer look at three active biotech companies in separate notes Friday morning.Molina Healthcare, […]
Four Billionaire Loved Biotech Stocks That Analysts Think Will DoubleAt Billionairesportfolio.com we actively manage a portfolio of the “best ideas” from the world’s best hedge funds, and our members get to follow along.Following the highest conviction trades of the world’s best hedge funds works especially well in the biotech sector. It gives you direct access to the smartest investment minds […]
